Complete skin clearance and Psoriasis Area and Severity Index response rates in clinical practice: predictors, health‐related quality of life improvements and implications for trea... von Norlin, J.M., Nilsson, K., Persson, U., Schmitt‐Egenolf, M.

Volltext

Complete skin clearance and beyond von Schmitt‐Egenolf, M.

Volltext

Prevalence and incidence of palmoplantar pustulosis in Sweden: a population‐based register study von Löfvendahl, S., Norlin, J. M., Schmitt‐Egenolf, M.

Volltext

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations von Nast, A., Smith, C., Spuls, P.I., Avila Valle, G., Bata‐Csörgö, Z., Boonen, H., De Jong, E., Garcia‐Doval, I., Gisondi, P., Kaur‐Knudsen, D., Mahil, S., Mälkönen, T., Maul, J.T., Mburu, S., Mrowietz, U., Reich, K., Remenyik, E., Rønholt, K.M., Sator, P.G., Schmitt‐Egenolf, M., Sikora, M., Strömer, K., Sundnes, O., Trigos, D., Van Der Kraaij, G., Yawalkar, N., Dressler, C.

Volltext

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations von Nast, A., Smith, C., Spuls, P.I., Avila Valle, G., Bata‐Csörgö, Z., Boonen, H., De Jong, E., Garcia‐Doval, I., Gisondi, P., Kaur‐Knudsen, D., Mahil, S., Mälkönen, T., Maul, J.T., Mburu, S., Mrowietz, U., Reich, K., Remenyik, E., Rønholt, K.M., Sator, P.G., Schmitt‐Egenolf, M., Sikora, M., Strömer, K., Sundnes, O., Trigos, D., Van Der Kraaij, G., Yawalkar, N., Dressler, C.

Volltext

What can we learn from ‘dropouts’ in clinical trials? von Schmitt‐Egenolf, M.

Volltext

Sustained Psoriasis Area and Severity Index, Dermatology Life Quality Index and EuroQol‐5D response of biological treatment in psoriasis: 10 years of real‐world data in the Swedish... von Hjalte, F., Carlsson, K.S., Schmitt‐Egenolf, M.

Volltext

Physical activity and lifestyle improvement in the management of psoriasis von Schmitt-Egenolf, M.

Volltext

Evaluating equality in psoriasis healthcare: a cohort study of the impact of age on prescription of biologics von Geale, K., Henriksson, M., Schmitt-Egenolf, M.

Volltext

Health‐related quality of life in patients with melanoma – characterization of a Swedish cohort von Tufvesson Stiller, H., Mikiver, R., Uppugunduri, S., Lindholm, C., Månsson Brahme, E., Schmitt‐Egenolf, M.

Volltext

Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI) von Hägg, D., Sundström, A., Eriksson, M., Schmitt-Egenolf, M.

Volltext

Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients von Norlin, J.M., Steen Carlsson, K., Persson, U., Schmitt-Egenolf, M.

Volltext

The higher proportion of men with psoriasis treated with biologics may be explained by more severe disease in men von Hägg, David, Eriksson, Marie, Sundström, Anders, Schmitt-Egenolf, Marcus

Volltext

Sustained Psoriasis Area and Severity Index, Dermatology Life Quality Index and EuroQol‐5D response of biological treatment in psoriasis: 10 years of real‐world data in the Swedish... von Hjalte, F., Carlsson, K.S., Schmitt‐Egenolf, M.

Volltext

Impact of Bariatric Surgery on Moderate to Severe Psoriasis: A Retrospective Nationwide Registry Study von Laskowski, Marta, Schiöler, Linus, Ottosson, Johan, Schmitt-Egenolf, Marcus, Wennberg, Ann-Marie, Olbers, Torsten, Torén, Kjell, Gustafsson, Helena

Volltext

Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudina... von Arana, Alejandro, Pottegård, Anton, Kuiper, Josephina G, Booth, Helen, Reutfors, Johan, Calingaert, Brian, Lund, Lars Christian, Crellin, Elizabeth, Schmitt-Egenolf, Marcus, Kaye, James A, Gembert, Karin, Rothman, Kenneth J, Kieler, Helle, Dedman, Daniel, Houben, Eline, Gutiérrez, Lia, Hallas, Jesper, Perez-Gutthann, Susana

Volltext

Severity of Psoriasis Differs Between Men and Women: A Study of the Clinical Outcome Measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish Register Patients von Hägg, David, Sundström, Anders, Eriksson, Marie, Schmitt-Egenolf, Marcus

Volltext

The Disruptive Force of Real-World Evidence von Schmitt-Egenolf, Marcus

Volltext

使用生物疗法治疗银屑病的持续 PASI、DLQI 及 EQ‐5D 结果:基于瑞典国家银屑病登记的十年真实数据 von Hjalte, F., Carlsson, K.S., Schmitt‐Egenolf, M.

Volltext

Challenges for Synthesising Data in a Network of Registries for Systemic Psoriasis Therapies von Ormerod, A.D., Augustin, M., Baker, C., Chosidow, O., Cohen, A.D., Dam, T.N., Garcia-Doval, I., Lecluse, L.L., Schmitt-Egenolf, M., Spuls, P.I., Watson, K.D., Naldi, L.

Volltext